CD4+ cell count stratification to guide tuberculosis preventive therapy for people living with HIV

Conclusion: TB incidence was high among all patients who did not receive IPT, including those with CD4+ cell count more than 350 cells/μl and negative or unknown TST results. TB preventive therapy should be provided to all people living with HIV in medium burden settings, regardless of CD4+ cell count and TST status.
Source: AIDS - Category: Infectious Diseases Tags: Epidemiology and Social Source Type: research